587. Meet-the-Professor: SSI Reporting and Prevention in 2014 and 2015
Session: Meet-the-Professor Session: Changes in SSI Reporting and Prevention in 2014 and 2015, Implications and Practice Change
Friday, October 4, 2013: 7:35 AM
Room: The Moscone Center: 300
Deborah Yokoe, MD, MPH, FIDSA, FSHEA, Brigham and Women's Hospital, Boston, MA

Dr. Yokoe is the Hospital Epidemiologist and medical director of Infection Control at Brigham and Women’s Hospital (BWH) and Dana-Farber Cancer Institute (DFCI) in Boston, MA, and an Associate Professor of Medicine at Harvard Medical School. Her research has focused on the development and evaluation of streamlined and reliable methods for performing surveillance for healthcare-associated infections, particularly surgical site infections. She is a member of the Massachusetts Department of Public Health Technical Advisory Group that provides oversight for the statewide mandatory reporting and healthcare-associated infection prevention program and a member of HICPAC. She is a SHEA Fellow and SHEA Councilor on the Board of Trustees. She co-chaired the task force that produced “A compendium of strategies to prevent healthcare-associated infections in acute care facilities”. The Compendium has been promoted by the IDSA, SHEA, the CDC, the Joint Commission, and the AHA as a tool to assist acute care hospitals to translate evidence-based best recommendations for prevention of healthcare-associated infections into practice. She also chaired the international working group that updated the infection prevention and control-related sections of the “Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective” which has been endorsed by many professional groups including IDSA, SHEA, and the CDC.

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.